068270.KS Stock — Price, Charts & Analysis

Celltrion, Inc. (068270.KS) has no trailing P/E shown and a forward P/E of 25.66x. This places 068270.KS in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

068270.KS trades with 25.66x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 068270.KS looks overvalued or undervalued.

068270.KS's P/E of 25.66x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

068270.KS's trailing EPS is not shown and forward EPS is ₩6,559.36. Reported earnings growth is 224.30%, which helps show current profit momentum.

Celltrion, Inc. has a market cap of ₩44.51T, making 068270.KS a large-cap stock based on the current market value shown on Worldtickers.

068270.KS's latest stock price on Worldtickers is ₩194,100.00. The latest move is ₩0.00 or 0.00%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

068270.KS's quote includes a latest price of ₩194,100.00. The market open is ₩199,100.00. Previous close is ₩194,100.00. The intraday range is ₩194,000.00 to ₩202,000.00.

068270.KS is up in the latest quote, with a move of ₩0.00 or 0.00%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

068270.KS generated ₩4.47T in trailing revenue. Revenue growth is 36.00%, which helps show whether demand is expanding or slowing.

068270.KS's revenue growth is 36.00%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 068270.KS shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is ₩1.27T.

Gross margin is 60.69%. Margins show how efficiently Celltrion, Inc. turns revenue into profit.

Celltrion, Inc. carries ₩3.87T and holds ₩1.42T in cash.

068270.KS holds ₩1.42T on its balance sheet.

Yes, Celltrion, Inc. pays a dividend of ₩714.29 per share annually. The dividend yield is 37.00%. The payout ratio is 10.45%.

068270.KS's dividend yield is 37.00%. Its payout ratio is 10.45%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for 068270.KS. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Celltrion, Inc.'s investor relations materials.

Institutions hold 20.44% of 068270.KS shares. Insiders hold 36.17% of shares. Ownership mix helps investors understand how much of Celltrion, Inc. is held by professional investors and company insiders.

068270.KS has 229.33M shares outstanding. Float shares are 152.2M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 068270.KS, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 068270.KS is ₩6,559.36. Earnings growth is 224.30%. Revenue growth is 36.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

068270.KS is in the Healthcare sector. Its earnings multiple is 25.66x. Its latest displayed growth metric is 36.00%. Compare these figures with sector peers before deciding whether Celltrion, Inc. is stronger or weaker than average.

068270.KS trades at ₩194,100.00. The stock trades at 25.66x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Celltrion, Inc.'s fundamentals.

068270.KS risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.32, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

068270.KS should be compared with companies in Biotechnology. Its earnings multiple is 25.66x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Celltrion, Inc. (068270.KS) operates in Healthcare, specifically Biotechnology. Celltrion, Inc., a biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products. It offers biosimilars, including Remsima for rheumatoid arthritis and inflammatory bowel disease; Truxima for non-hodgkin's lymphoma and chronic lymphocytic leukemia; Herzuma for metastatic breast and gastric cancer; Remsima SC and Yuflyma for rheumatoid arthritis and inflammatory bowel disease; Vegzelma for metastatic colorectal cancer and non-small cell lung ca

068270.KS trades on KSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

068270.KS stock is priced in KRW on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Celltrion, Inc.'s official website listed on Worldtickers is www.celltrion.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Celltrion, Inc. is headquartered in Incheon, South Korea. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

068270.KS is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

068270.KS has traded between ₩158,500.00 and ₩239,047.62 over the past 52 weeks. At ₩194,100.00, it is 18.80% below the high and 22.46% above the low. The 52-week range helps gauge long-term price momentum.

068270.KS is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is ₩180,214.00 and its 200-day moving average is ₩187,253.50.

068270.KS's RSI is 55.11. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

068270.KS's latest RSI reading is 55.11, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 068270.KS is near ₩170,000.00. Key resistance is near ₩212,000.00. Breaks above resistance or below support can change the short-term technical setup.

068270.KS's nearest reported support level is ₩170,000.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

068270.KS's nearest reported resistance level is ₩212,000.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

068270.KS trades about 686.51K shares daily on average. The latest displayed volume is 484.27K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

068270.KS's MACD is -275.38, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

068270.KS is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 55.11 (neutral). MACD is bearish. Nearest support is around ₩170,000.00. Resistance is around ₩212,000.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is ₩190,770.00 (1.75% from price). MA50 is ₩180,214.00 (7.71% from price). MA200 is ₩187,253.50 (3.66% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 068270.KS's MA20 is ₩190,770.00. MA50 is ₩180,214.00. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

068270.KS's pivot is near ₩193,733.33. Support is near ₩170,000.00. Resistance is near ₩212,000.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for 068270.KS is near ₩185,700.68. The next upper resistance zone is near ₩202,142.86. These levels help define risk and possible follow-through zones after a breakout or breakdown.

068270.KS's Bollinger range is roughly ₩170,470.93 to ₩211,069.07. Band width is near 21.28%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

068270.KS's ATR-based typical daily range is about 3.90%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 484.27K shares. Average volume is about 686.51K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

068270.KS's all-time high shown on Worldtickers is ₩325,235.47. Its all-time low is ₩1,660.27. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

068270.KS has a beta of 0.32, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.